US Stock MarketDetailed Quotes

BLAC Bellevue Life Sciences Acquisition

Watchlist
  • 11.350
  • 0.0000.00%
Close Jan 3 15:39 ET
45.87MMarket Cap-96.19P/E (TTM)

Bellevue Life Sciences Acquisition Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-58.41%-226.88K
-307.45%-1.42M
13.72%-41.78K
-19,233.32%-818.77K
-29,258.51%-279.49K
-3,879.05%-143.23K
-4,903.90%-347.62K
-38,333.33%-48.43K
-818.66%-4.24K
-686.78%-952
Net income from continuing operations
-395.41%-230.96K
-132.27%-97.3K
-154.78%-60.43K
1,241.01%403.78K
-504.63%-86.17K
490.49%78.18K
30,612.55%301.46K
87,643.65%110.31K
-969.77%-35.39K
-4,326.09%-14.25K
Other non cash items
56.47%-269.2K
42.55%-465.51K
-15.10%-480.82K
---2.78M
---928.76K
---618.5K
---810.3K
---417.73K
----
----
Change In working capital
-31.18%273.29K
-629.46%-853.58K
92.85%499.47K
4,884.26%1.55M
5,429.63%735.44K
1,567.60%397.09K
2,805.44%161.22K
--259K
994.24%31.15K
6,516.92%13.3K
-Change in prepaid assets
-38.98%20.34K
-27.70%16.83K
29.28%-57.34K
---7.21K
--17.25K
--33.34K
--23.28K
---81.07K
--0
--0
-Change in payables and accrued expense
-30.46%252.95K
-731.01%-870.41K
63.73%556.81K
4,907.39%1.56M
5,299.92%718.19K
1,427.61%363.75K
2,414.80%137.94K
--340.07K
994.24%31.15K
6,516.92%13.3K
Cash from discontinued investing activities
Operating cash flow
-58.41%-226.88K
-307.45%-1.42M
13.72%-41.78K
-19,233.32%-818.77K
-29,258.51%-279.49K
-3,879.05%-143.23K
-4,903.90%-347.62K
-38,333.33%-48.43K
-818.66%-4.24K
-686.78%-952
Investing cash flow
Cash flow from continuing investing activities
-150K
17.2M
99.83%-120K
-33.83M
36.38M
0
0
-70.21M
0
0
Net other investing changes
---150K
--17.2M
99.83%-120K
---33.83M
--36.38M
--0
--0
---70.21M
----
----
Cash from discontinued investing activities
Investing cash flow
---150K
--17.2M
99.83%-120K
---33.83M
--36.38M
--0
--0
---70.21M
--0
--0
Financing cash flow
Cash flow from continuing financing activities
35.00%270K
-15.67M
-99.79%150K
27,759.15%34.54M
-63,932.58%-36.14M
2,290.82%200K
0
599,170.70%70.48M
315.86%123.98K
1,472.56%56.62K
Net issuance payments of debt
40.00%280K
--1.36M
111.25%135K
-250.00%-1.2M
-166.67%-200K
--200K
--0
-1,300.00%-1.2M
700.00%800K
--300K
Net common stock issuance
--0
---17.05M
--0
--27.97M
---36M
--0
--0
--63.97M
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--9.16M
--0
--0
--0
--9.16M
--0
--0
Net other financing activities
---10K
--10K
101.04%15K
-105.95%-1.39M
122.60%55K
--0
--0
-1,540.17%-1.45M
-329.40%-676.02K
-5,800.17%-243.38K
Cash from discontinued financing activities
Financing cash flow
35.00%270K
---15.67M
-99.79%150K
27,759.15%34.54M
-63,932.58%-36.14M
2,290.82%200K
--0
599,170.70%70.48M
315.86%123.98K
1,472.56%56.62K
Net cash flow
Beginning cash position
9,986.03%119.12K
-98.96%3.64K
-87.62%15.42K
2,517.22%124.5K
-15.81%57.96K
-98.41%1.18K
2,027.88%348.8K
2,517.22%124.5K
-92.41%4.76K
664.58%68.84K
Current changes in cash
-288.26%-106.88K
133.22%115.48K
-105.25%-11.78K
-191.10%-109.08K
-176.41%-42.54K
1,163.38%56.77K
-701.61%-347.62K
1,827.81%224.3K
306.83%119.74K
1,411.02%55.67K
End cash Position
-78.89%12.24K
9,986.03%119.12K
-98.96%3.64K
-87.62%15.42K
-87.62%15.42K
-15.81%57.96K
-98.41%1.18K
2,027.88%348.8K
2,517.22%124.5K
2,517.22%124.5K
Free cash flow
-58.41%-226.88K
-307.45%-1.42M
13.72%-41.78K
-19,233.32%-818.77K
-29,258.51%-279.49K
-3,879.05%-143.23K
-4,903.90%-347.62K
-38,333.33%-48.43K
-818.66%-4.24K
-686.78%-952
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -58.41%-226.88K-307.45%-1.42M13.72%-41.78K-19,233.32%-818.77K-29,258.51%-279.49K-3,879.05%-143.23K-4,903.90%-347.62K-38,333.33%-48.43K-818.66%-4.24K-686.78%-952
Net income from continuing operations -395.41%-230.96K-132.27%-97.3K-154.78%-60.43K1,241.01%403.78K-504.63%-86.17K490.49%78.18K30,612.55%301.46K87,643.65%110.31K-969.77%-35.39K-4,326.09%-14.25K
Other non cash items 56.47%-269.2K42.55%-465.51K-15.10%-480.82K---2.78M---928.76K---618.5K---810.3K---417.73K--------
Change In working capital -31.18%273.29K-629.46%-853.58K92.85%499.47K4,884.26%1.55M5,429.63%735.44K1,567.60%397.09K2,805.44%161.22K--259K994.24%31.15K6,516.92%13.3K
-Change in prepaid assets -38.98%20.34K-27.70%16.83K29.28%-57.34K---7.21K--17.25K--33.34K--23.28K---81.07K--0--0
-Change in payables and accrued expense -30.46%252.95K-731.01%-870.41K63.73%556.81K4,907.39%1.56M5,299.92%718.19K1,427.61%363.75K2,414.80%137.94K--340.07K994.24%31.15K6,516.92%13.3K
Cash from discontinued investing activities
Operating cash flow -58.41%-226.88K-307.45%-1.42M13.72%-41.78K-19,233.32%-818.77K-29,258.51%-279.49K-3,879.05%-143.23K-4,903.90%-347.62K-38,333.33%-48.43K-818.66%-4.24K-686.78%-952
Investing cash flow
Cash flow from continuing investing activities -150K17.2M99.83%-120K-33.83M36.38M00-70.21M00
Net other investing changes ---150K--17.2M99.83%-120K---33.83M--36.38M--0--0---70.21M--------
Cash from discontinued investing activities
Investing cash flow ---150K--17.2M99.83%-120K---33.83M--36.38M--0--0---70.21M--0--0
Financing cash flow
Cash flow from continuing financing activities 35.00%270K-15.67M-99.79%150K27,759.15%34.54M-63,932.58%-36.14M2,290.82%200K0599,170.70%70.48M315.86%123.98K1,472.56%56.62K
Net issuance payments of debt 40.00%280K--1.36M111.25%135K-250.00%-1.2M-166.67%-200K--200K--0-1,300.00%-1.2M700.00%800K--300K
Net common stock issuance --0---17.05M--0--27.97M---36M--0--0--63.97M--0--0
Proceeds from stock option exercised by employees --0--0--0--9.16M--0--0--0--9.16M--0--0
Net other financing activities ---10K--10K101.04%15K-105.95%-1.39M122.60%55K--0--0-1,540.17%-1.45M-329.40%-676.02K-5,800.17%-243.38K
Cash from discontinued financing activities
Financing cash flow 35.00%270K---15.67M-99.79%150K27,759.15%34.54M-63,932.58%-36.14M2,290.82%200K--0599,170.70%70.48M315.86%123.98K1,472.56%56.62K
Net cash flow
Beginning cash position 9,986.03%119.12K-98.96%3.64K-87.62%15.42K2,517.22%124.5K-15.81%57.96K-98.41%1.18K2,027.88%348.8K2,517.22%124.5K-92.41%4.76K664.58%68.84K
Current changes in cash -288.26%-106.88K133.22%115.48K-105.25%-11.78K-191.10%-109.08K-176.41%-42.54K1,163.38%56.77K-701.61%-347.62K1,827.81%224.3K306.83%119.74K1,411.02%55.67K
End cash Position -78.89%12.24K9,986.03%119.12K-98.96%3.64K-87.62%15.42K-87.62%15.42K-15.81%57.96K-98.41%1.18K2,027.88%348.8K2,517.22%124.5K2,517.22%124.5K
Free cash flow -58.41%-226.88K-307.45%-1.42M13.72%-41.78K-19,233.32%-818.77K-29,258.51%-279.49K-3,879.05%-143.23K-4,903.90%-347.62K-38,333.33%-48.43K-818.66%-4.24K-686.78%-952
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Hutchmed (China)
HCM
+6.61%
Ermenegildo Zegna NV
ZGN
+2.34%
New Fortress Energy
NFE
+2.32%
Enerpac Tool
EPAC
+1.91%
eBay
EBAY
+1.74%

Unlock the Full List